Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2010 | 1 |
2012 | 1 |
2013 | 2 |
2015 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Obesity, inflammation, and insulin resistance.
Gastroenterology. 2007 May;132(6):2169-80. doi: 10.1053/j.gastro.2007.03.059.
Gastroenterology. 2007.
PMID: 17498510
Review.
Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets.
Romeo GR, Lee J, Shoelson SE.
Romeo GR, et al.
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6. doi: 10.1161/ATVBAHA.111.241869.
Arterioscler Thromb Vasc Biol. 2012.
PMID: 22815343
Free PMC article.
Review.
Item in Clipboard
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.
Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE; Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team.
Goldfine AB, et al.
Ann Intern Med. 2013 Jul 2;159(1):1-12. doi: 10.7326/0003-4819-159-1-201307020-00003.
Ann Intern Med. 2013.
PMID: 23817699
Free PMC article.
Clinical Trial.
Item in Clipboard
Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus.
Rubin MR, Goldfine AB, McMahon DJ, Donovan DS, Cremers S, Dworakowski E, Schaefer EJ, Shoelson SE, Silverberg SJ.
Rubin MR, et al.
Endocrine. 2015 Nov;50(2):504-7. doi: 10.1007/s12020-015-0535-8. Epub 2015 Feb 1.
Endocrine. 2015.
PMID: 25636441
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team.
Goldfine AB, et al.
Ann Intern Med. 2010 Mar 16;152(6):346-57. doi: 10.7326/0003-4819-152-6-201003160-00004.
Ann Intern Med. 2010.
PMID: 20231565
Free PMC article.
Clinical Trial.
Item in Clipboard
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).
Goldfine AB, Buck JS, Desouza C, Fonseca V, Chen YD, Shoelson SE, Jablonski KA, Creager MA; TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team.
Goldfine AB, et al.
Diabetes Care. 2013 Dec;36(12):4132-9. doi: 10.2337/dc13-0859. Epub 2013 Oct 15.
Diabetes Care. 2013.
PMID: 24130358
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite